Selected Abstracts
Hypertension
Preadolescent and adolescent
h 
Renal mass and blood pressure in normal children
Genetics
h
Deletion polymorphism of the ACE gene is a risk factor for target
organ damage in essential hypertension
Hormonal aberrations
h
Atrial natriuretic peptide is reduced both in white and black
salt-sensitive hypertensives
h
Endogenous erythropoietin correlates with arterial blood pressure in
essential hypertension
Kidney in hypertension
h
Nephrosclerosis in the white: no correlation between hypertension and
renal histologic lesion
h
Microalbuminuria and the renal vascular response to L-arginine
in essential hypertension
h
Losartan reduces albuminuria in patients with essential
hypertension
Ambulatory monitoring
h
Diurnal blood pressure variation in normotensive and hypertensive
children and adolescents
Tests for LVH
h
Left ventricular hypertrophy and systolic dysfunction in non-
insulin dependent diabetic patients with and without diabetic nephropathy
Elderly
h
Salt loading and hypertension in the elderly
Ethnic populations
h
Nocturnal blood pressure in treated hypertensive African
Americans compared to treated hypertensive European Americans
h
Do racial differences exist for early target organ damage in
essential hypertension
Renovascular hypertension
h
Outcomes and risks of renal revascularization in azotemic
atherosclerotic patients
Renal transplant patients
h
In kidney transplanted patients developing graft renal artery
stenosis erythrosis appears before blood pressure increases
h
Cyclosporine A-induced salt sensitive hypertension: role of nitric
oxide
Women
h
Birth weight and adult hypertension in women
h
Second trimester 24-hour ambulatory blood pressure monitoring: can it
predict the development of hypertension in primigravidae?
ACE inhibitors
h
Prolonged treatment with the renin inhibitor Remikiren in hypertensive
patients with different degrees of impaired renal function
Alpha and alpha/beta blockers
h
Captopril and doxasozin induce similar change in renal
hemodynamics in hypertensive patients with diabetes mellitus
Dialysis, Chronic Renal Failure
Vascular Access: graft/fistula
d
The relation of brachial artery flow to access flow
d
The relation of recirculation to access flow
d
The relation of intra-access pressure to intra-access flow
d
Do patients with angiographically proven access stenosis have low
access blood flow?
d
Access blood flow measurements in the low flow range by an
ultrasonic device are accurate
d
A new, Fick-principle based method for measuring blood flow in
hemodialysis grafts validated by magnetic resonance angiography
d
Access recirculation by ultrasonic dilution compared to a 20
sec slow flow method
d
Simplified accurate measurement of access recirculation with an in-
line hematocrit device
d
Extracorporeal venous drip chamber pressure measurement screening does
not predict impending hemodialysis access graft failure
d
Increasing AV fistulas for hemodialysis access
d
Measurement of access flow by thermodilution: in vitro experiments
d
Mutation at Arg506 of coagulation factor V and access
thrombosis in hemodialysis patients
d
The efficacy and complications of aspirin versus heparin in
post-operative prophylaxis against thrombosis in newly placed
hemodialysis access
Vascular Access: venous
d
Blood recirculation in central temporary catheters for acute
hemodialysis
Dialyzers
d
In vitro clearance of advanced glycosylated end-products by
conventional and high flux hemodialysis membranes
Complications (acute)
d
The protective effect of cool dialysate is dependent on patients'
predialysis body temperature
d
Relationship between blood volume and inferior cava diameter during
and after short and long hemodialysis
d
The intradialytic effects of oral L-carnitine: results of a
double blind placebo controlled trial
Dialysis machines
d
Safety of hemodialysis machines: Surveillance of the venous blood
return
Home hemodialysis
d
Long-term combination home automated peritoneal dialysis and in-center
hemodiafiltration for progressive neuropathy in end stage renal
disease
Adequacy, prescription, urea kinetics
d
Screening for extreme postdialysis urea rebound using the Smye
method
d
Cardiac index affects urea rebound to the extent predicted by
the regional blood flow model
d
Effect of intradialytic exercise on urea kinetics and rebound
d
Intradialytic exercise increases effective dialysis efficiency and
reduces rebound
Physiology
d
Fluctuations of urea generation rate following protein intake
in hemodialysis patients measured using [13-C]-urea
Reuse, theory and practice
d
Heat sterilization of dialyzers: maximized reuse with 1.5% citric
acid and 95 degrees C
d
Effect of Renalin reprocessing on small and large solute
clearances by hemodialyzers
Cardiovascular/Hypertension
d
Hypoalbuminemia: a major risk factor for cardiac disease in
ESRD
d
Hypertension, cardiomyopathy, cardiac morbidity and mortality in ESRD
d
Increased homocysteine values, a risk factor for premature coronary
artery disease, prevail in patients on hemodialysis
d
The effect of fluid loading on blood pressure in hemodialysis
patients
d
Arteriosclerosis, not atherosclerosis is common in end-stage renal
disease: related factors
d
Sudden cardiac death and autonomic nerve dysfunction in
hemodialysis patients
d
Effect of blood pressure on survival in a prevalent cohort of
hemodialysis patients
GI/Liver, Hepatitis
d
Long-term virological response after alpha-interferon therapy in HCV-
positive hemodialysis patients
d
Trends in the incidence of hepatitis C infection in hemodialysis units
d
Dialysis room and reuse strategies that affect the incidence of
hepatitis C infection in HD units
d
Beta-2-microglobulin amyloidosis involving the GI tract in
hemodialysis
Neurological
d
Severe neuropathy predicts mortality in non-diabetic dialysis
patients
Anemia/Erythropoietin/Iron
d
Role of endogenous erythropoietin in the hematopoietic response to
iron administration in hemodialysis patients
d
Interferon-gamma mediates resistance to erythropoietin in
uremic patients with inflammatory disease
d
Response to iron dextran therapy is not precluded by high serum
ferritin
d
Endogenous erythropoietin levels are elevated in patients on
continuous ambulatory peritoneal dialysis
d
Factors predictive of suboptimal iron stores in hemodialysis patients
with normal iron indices
d
Amelioration of left ventricular hypertrophy in long-term hemodialysis
patients
d
Effect of chronic human erythropoietin therapy on immune
response in chronic hemodialysis patients
d
Cell therapy for erythropoeitin-deficient anemias
d
Underdialysis impairs response to erythropoietin in
hemodialysis patients
d
Low iron absorption in erythropoietin-treated haemodialysis
patients
d
Can the erythropoietin dose be lowered safely? A case-control study of
subcutaneous administration
d
The safety and efficacy of intraperitoneal erythropoietin in
children on CCPD
d
Correction of anemia does not improve growth or endocrine function
in children with ESRD: A report from the U.S. multicenter pediatric
recombinant erythropoietin study
d
Comparison of 3 iron dextran infusion methods to correct anemia in
erythropoietin treated hemodialysis patients
Bone disease/aluminum
d
High phosphorus directly simulates PTH secretion by human
parathyroid tissue
d
Bone mineral loss in chronic renal failure: a difference between young
and old CRF patients
d
Low-dose DFO treatment (5 mg/kg) in acutely aluminum
intoxicated dialysis patients using two drug administration schedules
d
Expression in pathalogic parathyroid tissue of calcium receptor and
vitamin D receptor gene message
d
Expression of Bcl-2 oncoprotein in parathyroid tissue of patients with
primary and secondary hyperparathyroidism
d
Calcium-regulated parathyroid hormone release before and after
successful long-term calcitriol therapy in secondary
hyperparathyroidism
d
Non-suppressible parathyroid hormone secretion is related to
parathyroid gland size in uremic secondary hyperparathyroidism
d
Serum phosphorus strongly correlates with PTH in mild chronic renal
failure
d
Suppression of PTH by 22-oxacalcitriol in hemodialysis patients with
secondary hyperparathyroidism
d
Marked expression of c-fos/jun proteins in hyperplastic parathyroid
glands
d
Mild osteodystrophy: Is it really a mild disease?
d
Nasal calcitonin reduces bone loss in renal transplant
recipients
d
Effect of aging on renal responsiveness to parathyroid hormone
in healthy men
d
In vivo effect of intravenous 1,25-dihydroxyvitamin D3 on
interleukin-2 production in hemodialysis patients
d
Serum parathyroid hormone levels as a peredictor of the skeletal
resopnse to intermittent calcitriol therapy
d
Phosphate restriction prevents parathyroid cell growth in uremic rats
and high phosphate directly stimulated PTH secretion in tissue culture
d
Secondary hyperparathyroidism complicated by parathyromatosis
d
Monoclonal proliferation of nodues in parathyroid hyperplasia
due to chronic renal failure
d
Vitamin D receptor gene polymorphism and severity of secondary
hyperparathyroidism
CRF and diabetes
d
Depletion of advanced glycated end-products (AGEs) in uremic serum and
dialysis fluid by an AGE-binding lysozyme-matrix
Infections (other than hepatitis, peritonitis)
d
Hepatitis C viral infection and HIV co-infection in
hemodialyzed patients
d
Access-related infection in HIV-seropositive dialysis patients:
comparison of hemodialysis to peritoneal dialysis
d
Preoperative vancomycin prophylaxis decreases the incidence of
hemodialysis vascular access infections
Nutrition
d
Increased dialysis prescription improved nutrition
d
Can we reconcile metabolic acidosis and nutritional status in
hemodialysis patients?
d
Elevated serum C-reactive protein is a strong predictor of
increased mortality and low serum albumin in hemodialysis patients
d
Lean body mass estimation by different techniques in healthy controls
and peritoneal dialysis patients
d
Dialysis adequacy and nutrition in CAPD: a prospective study
d
Use of a 1.1% amino acid dialysis solution to treat
malnutrition in peritoneal dialysis patients
d
Linkage between adequacy of dialysis and nutrition in CAPD patients
d
Predictors of malnutrition in maintenance hemodialysis patients
d
Effect of insulin-like growth factor 1 on nitrogen balance in
malnourished CAPD patients
Outcomes (Morbidity, Mortality)
d
Residual renal function in hemodialysis and continuous ambulatory
peritoneal dialysis patients
d
High cytokine levels may mediate the high mortality of
hemodialysis patients with low albumin and cholesterol
d
Patient survival on CAPD: comparison between Canada and the United
States
d
Cardiac disease in endstage renal disease: A comparison of
hemodialysis and peritoneal dialysis
d
Comparison of mortality risk by Kt/V single pool vs. double pool
analysis in diabetic and non-diabetic dialysis patients
d
Effect of serial APACHE and organ failure scores on prediction of
mortality in acute renal failure
d
Association of serum bicarbonate to survival in hemodialysis: a
non-linear relationship
d
Early death in dialysis patients: risk factors and impact on incidence
and mortality rates
d
Predictors of short-term mortality in diabetic hemodialysis
patients
Complications of PD
d
Increased risk of adverse outcome in immunosuppressed patients
undergoing CAPD
PD solutions, equipment
d
Effect of amino acid based dialysate on peritoneal blood flow and
permeability during CAPD
d
CAPD using a self-made, ultrafiltration-sterilized, bicarbonate-based
solution
PET testing
d
Correlation between peritoneal transport type and peritoneal
protein losses
Physiology
d
Pressure causes fluid loss from the peritoneal cavity to the
body
d
Effect of acutely raising the serum albumin on peritoneal transport
and ultrafiltration in CAPD patients
Peritonitis and exit-site infection
d
Bacteria grow better if pH of CAPD solutions is elevated from
5.0 to 6.4, offsetting improvement in neutrophil phagocytosis
d
Peritonitis influences mortality in PD patients
Chronic PD regimens, adequacy, modeling
d
The creatinine excretion ratio is an unreliable indicator of non-
compliance in PD patients
d
Urea and weekly creatinine clearances measured by direct
quantification: Comparison in APD, CAPD, and conventional HD
d
Formula to calculate nitrogen losses in patients treated with chronic
peritoneal dialysis
d
Comparison of 2 year survival on hemodialysis and peritoneal dialysis
with dose of dialysis matched using the peak concentration hypothesis
d
Association between adequacy and nutrition in CAPD -- genuine or
artifact?
Etiology
d
Attribution of hypertension as the underlying cause of ESRD: does
race matter?
d
Low birth weight a risk factor for development of diabetic
nephropathy?
Progression
d
ACE gene polymorphism and progression of renal disease
d
Urinary transforming growth factor beta-1 and progression of
glomerular diseases
d
Magnitude of end-stage renal disease in IDDM: 35 year follow-up
study
d
Effect of dietary protein restriction on the progression of non-
diabetic renal disease: meta-analysis
Continous therapies
d
Limiting continuous venovenous hemofiltration in acute renal failure
d
Treatment of volume overload in patients with acute renal
failure by intermittent hemodialysis
d
Microspheres for specific adsorption as supplement for hemodialysis in
acute renal failure
d
Cytokine removal and cardiovascular hemodynamics in patiens
with ARF and treatment with CVVH
d
Incidence of hypothermia during continuous renal replacement
therapy
d
Bicarbonate dialysate for continuous renal replacement therapy
d
Continuous veno-venous hemodialysis in septic patients
Clinical Nephrology
Reduced circulatory volume/sepsis/hepatorenal
c
Is the administration of dopamine associated with adverse outcomes in
acute renal failure?
c
The role of loop diuretics in acute renal failure? A double-
blind, randomised controlled trial
Cyclosporine, ARF in transplant patients
c
Thyroid hormone for treatment of acute tubular necrosis in
renal allografts: a prospective, randomized trial
Embolic disease
c
Focal segmental glomerulosclerosis due to cholesterol atheroembolic
disease: Clinicopathologic correlations
Acute glomerulonephritis/RPGN
c
Effect of initial histology and plasmapheresis treatment on
prognosis in RPGN: results of the German prospective randomized
multicenter study
c
Superantigen-related glomerulonephritis and vasculitis due to MRSA
infection
Acute interstitial nephritis/NSAID
c
Renal gallium scintigraphy helps decision-making in acute renal
failure
Radiocontrast media
c
Effect of hemodialysis after contrast media application in
adults with renal insufficiency
Post surgical
c
Acute renal failure following cardiac surgery
Urinary tract obstruction
c
Distinctive effects between obstructive and non-obstructive
pyelocaliectasis by duplex-Doppler ultrasonography
Infections (other than hepatitis, peritonitis)
c
Outcome of HIV-infected patients on hemodialysis
Hereditary polycystic disease
c
Autosomal dominant polycystic kidney disease patients are at risk for
recurrent intracranial aneurysms
c
Rate of loss of renal function in hypertensive and normotensive
autosomal dominant polycystic kidney disease patients
Hyperkalemia
c
Trimethoprim/sulfamethoxazole in standard dose causes
hyperkalemia
c
Hyporeninemia is associated with erythropoietin deficiency in
type I diabetic patients
c
Examination for the thiazide-sensitive Na-Cl cotransporter as a
candidate gene in Gordon's syndrome
Renal biopsy techniques, tips, complications
c
Bleeding time does not predict bleeding complications post
renal biopsy
c
Timing of complications in percutaneous renal biopsy: what is
the optimal period of observation?
Diabetes
c
Effect of nondihydropyridine calcium antagonists on progression of
nephropathy from non-insulin dependent diabetics: a five year
follow-up study
c
The ACE gene polymorphism in patients with diabetic nephropathy
c
Short-term comparison of ACE inhibition vs. calcium channel blockade
in African Americans with type II diabetic nephropathy
c
Long-term effect of captopril on kidney function in normotensive
insulin-dependent diabetic patients with diabetic nephropathy
c
Correlates of diabetic and non-diabetic renal disease in NIDDM
c
Smoking -- a major predictor of nephropathy in newly diagnosed type
II diabetes
c
Kidney/pancreas transplant versus kidney transplant alone
c
Efficacy of captopril in normotensive diabetic patients with
microalbuminuria - 8 years follow up
c
Progression of overt diabetic nephropathy: Role of metabolic control
c
Glomerular structure in long term type II diabetes with and
without microalbuminuria
c
Cyclosporine nephrotoxicity in insulin-dependent diabetic
patients: an eight year follow up
c
Renal production of TGF-beta is increased in diabetic patients
c
Progression of diabetic nephropathy and the insertion/deletion
polymorphismof the ACE gene
Focal, collapsing, fibrillary GN
c
The impact of plasmapheresis on recurrent focal glomerular
sclerosis in renal allografts
c
Results of a 6 month randomized control trial of cyclosporine versus
placebo in adults with steroid-resistant, idiopathic, focal segmental
glomerulosclerosis
c
Glomerular number in focal segmental glomerulosclerosis and
minimal change nephrotic syndrome
IgA Nephropathy
c
The deletion polymorphism in the ACE gene is a risk factor for the
progression to renal failure independent of the M235T polymorphism in
the angiotensinogen gene
c
A family history of hypertension is associated to
nephrosclerosis and predicts the future onset of hypertension in
patients with IgA nephropathy
Hepatitis-associated nephropathy
c
Infection with hepatitis C virus increases the risk of de novo
glomerulonephritis in renal transplant recipients
c
Serological and virological profiles in renal transplant
candidates
c
Liver histology in renal transplant patients after more than 10
years of HCV infection
c
Localization of HCV in renal tissue of HCV-infected patients with
cryoglobulinemic mesangiocapillary glomerulonephritis: an immuno-
histochemical study
c
Glomerular disease in HIV-infected patients with hepatitis C
virus
HIV-associated nephropathy
c
Clinicopathologic evaluation of prednisone treatment or patients with
HIV nephropathy
c
Response to early and prolonged inhibition of angiotensin converting
enzyme in HIV-associated nephropathy
c
HIV/AIDS as a cause of renal failure
c
Contribution of globulins to plasma oncotic pressure and the
presence of edema in HIV patients with proteinuria
c
Cryoglobulinemia in HIV-infected patients with renal disease
c
Captopril increases renal survival in patients with HIV
nephropathy
c
Absence of edema in HIV-infected patients with ESRD
c
Prednisone ameliorates the progression on HIV-associated
nephropathy
c
Decreasing incidence of severe acute renal failure in patients with
HIV infection
c
Renal disease prevalence and risk factors among HIV-infected
inner city residents
c
Are we missing an epidemic of HIV-associated nephropathy?
Lupus nephritis
c
Renal lesions in drug induced lupus syndromes
Membranous GN
c
Changing incidence of idiopathic glomerular diseases in adults
c
Therapy of membranous glomerulonephritis with nephrotic syndrome. Five
year follow-up of a prospective, randomized study
c
Urinary C5b-9 in early and advanced renal insufficiency in
membranous nephropathy
Vasculitis (Wegener's PAN, etc.)
c
Assessing the severity of renal disease in systemic vasculitis: how to
the histopathologic data predict renal outcome?
c
Prevention of relapses in systemic vasculitis
c
ANCA-associated vasculitis and renal involvement: preliminary results
of a prospective randomized study comparing daily oral versus monthly I.V.
cyclophosphamide application
c
Humanized monoclonal antibody therapy for Wegener's
granulomatosis
c
Prevention of relapses of Wegener's granulomatosis by treatment with
co-trimoxazole. A placebo controlled trial.
c
Outcome of children with ANCA positive glomerulonephritis
Renal Stones: Diagnosis
c
Primary hyperoxaluria types I and II: clinical and lithogenic features
Renal Stones: Etiology
c
Decreased bone formation in idiopathic hypercalciuric calcium stone
formers explains reduced bone density
c
A prospective study of dietary and supplemental calcium and the risk
of kidney stones in women
Use back arrow on your browser to go back to HDCN home page (faster)
or click on the arrow.